アステラス製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2010/06/08 | 2,900 | 2,919 | 2,890 | 2,908 | -26 | -0.9% | 1,770,200 |
| 2010/06/07 | 2,950 | 2,962 | 2,928 | 2,934 | -35 | -1.2% | 2,960,300 |
| 2010/06/04 | 2,985 | 2,997 | 2,960 | 2,969 | +22 | +0.7% | 2,352,500 |
| 2010/06/03 | 2,990 | 3,000 | 2,943 | 2,947 | +35 | +1.2% | 2,413,700 |
| 2010/06/02 | 2,920 | 2,936 | 2,900 | 2,912 | -19 | -0.6% | 2,433,300 |
| 2010/06/01 | 2,938 | 2,958 | 2,871 | 2,931 | -4 | -0.1% | 1,718,800 |
| 2010/05/31 | 2,930 | 2,978 | 2,905 | 2,935 | +50 | +1.7% | 2,290,700 |
| 2010/05/28 | 2,891 | 2,908 | 2,853 | 2,885 | +15 | +0.5% | 4,596,000 |
| 2010/05/27 | 2,860 | 2,890 | 2,831 | 2,870 | -40 | -1.4% | 4,169,000 |
| 2010/05/26 | 2,937 | 2,976 | 2,904 | 2,910 | -48 | -1.6% | 3,420,900 |
| 2010/05/25 | 2,965 | 2,974 | 2,926 | 2,958 | -21 | -0.7% | 2,120,200 |
| 2010/05/24 | 2,982 | 3,015 | 2,961 | 2,979 | +5 | +0.2% | 2,655,800 |
| 2010/05/21 | 3,010 | 3,030 | 2,959 | 2,974 | -111 | -3.6% | 3,724,300 |
| 2010/05/20 | 3,110 | 3,120 | 3,070 | 3,085 | -60 | -1.9% | 2,501,400 |
| 2010/05/19 | 3,120 | 3,215 | 3,115 | 3,145 | -15 | -0.5% | 2,599,900 |
| 2010/05/18 | 3,120 | 3,210 | 3,120 | 3,160 | +25 | +0.8% | 2,641,900 |
| 2010/05/17 | 3,095 | 3,155 | 3,070 | 3,135 | -10 | -0.3% | 3,418,600 |
| 2010/05/14 | 3,115 | 3,170 | 3,110 | 3,145 | -30 | -0.9% | 2,962,800 |
| 2010/05/13 | 3,160 | 3,175 | 3,110 | 3,175 | -35 | -1.1% | 1,924,200 |
| 2010/05/12 | 3,190 | 3,215 | 3,185 | 3,210 | +20 | +0.6% | 1,369,600 |
| 2010/05/11 | 3,215 | 3,230 | 3,175 | 3,190 | +15 | +0.5% | 2,110,200 |
| 2010/05/10 | 3,120 | 3,205 | 3,115 | 3,175 | +15 | +0.5% | 1,744,900 |
| 2010/05/07 | 3,135 | 3,190 | 3,115 | 3,160 | -45 | -1.4% | 2,942,400 |
| 2010/05/06 | 3,235 | 3,245 | 3,200 | 3,205 | -100 | -3% | 3,120,800 |
| 2010/04/30 | 3,285 | 3,315 | 3,250 | 3,305 | +75 | +2.3% | 2,091,900 |
| 2010/04/28 | 3,270 | 3,275 | 3,200 | 3,230 | -80 | -2.4% | 2,420,200 |
| 2010/04/27 | 3,350 | 3,365 | 3,300 | 3,310 | -80 | -2.4% | 2,389,900 |
| 2010/04/26 | 3,345 | 3,395 | 3,345 | 3,390 | +70 | +2.1% | 1,506,600 |
| 2010/04/23 | 3,360 | 3,360 | 3,305 | 3,320 | -45 | -1.3% | 1,757,300 |
| 2010/04/22 | 3,410 | 3,430 | 3,345 | 3,365 | -65 | -1.9% | 1,659,400 |
| 2010/04/21 | 3,430 | 3,450 | 3,420 | 3,430 | +40 | +1.2% | 1,112,300 |
| 2010/04/20 | 3,380 | 3,420 | 3,380 | 3,390 | +10 | +0.3% | 1,317,400 |
| 2010/04/19 | 3,440 | 3,450 | 3,375 | 3,380 | -75 | -2.2% | 1,600,700 |
| 2010/04/16 | 3,450 | 3,460 | 3,440 | 3,455 | +10 | +0.3% | 1,232,600 |
| 2010/04/15 | 3,470 | 3,470 | 3,440 | 3,445 | -5 | -0.1% | 946,300 |
| 2010/04/14 | 3,450 | 3,480 | 3,440 | 3,450 | +5 | +0.1% | 1,196,200 |
| 2010/04/13 | 3,455 | 3,465 | 3,425 | 3,445 | -10 | -0.3% | 1,339,500 |
| 2010/04/12 | 3,470 | 3,485 | 3,440 | 3,455 | +5 | +0.1% | 1,361,400 |
| 2010/04/09 | 3,395 | 3,460 | 3,395 | 3,450 | +30 | +0.9% | 2,952,900 |
| 2010/04/08 | 3,430 | 3,460 | 3,400 | 3,420 | -40 | -1.2% | 1,359,700 |
| 2010/04/07 | 3,445 | 3,475 | 3,430 | 3,460 | +15 | +0.4% | 1,481,500 |
| 2010/04/06 | 3,425 | 3,470 | 3,425 | 3,445 | +20 | +0.6% | 1,515,500 |
| 2010/04/05 | 3,450 | 3,480 | 3,415 | 3,425 | ±0 | ±0% | 1,059,700 |
| 2010/04/02 | 3,445 | 3,445 | 3,410 | 3,425 | +10 | +0.3% | 919,800 |
| 2010/04/01 | 3,455 | 3,480 | 3,400 | 3,415 | - | - | 2,257,900 |
3651～
3695
件表示中 / 3695件
類似銘柄と比較する
現在ご覧いただいている「アステラス薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| アステラス薬 | 139,600円 | +0.9% | +380.2% | 5.59% | 19.23倍 | 1.65倍 |
|
医薬品国内２位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
| 武 田 | 423,400円 | -1.1% | +75.3% | 4.72% | 29.00倍 | 0.95倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位１０強入り |
| 大塚ＨＤ | 707,500円 | +2.2% | +10.2% | 1.70% | 13.59倍 | 1.37倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界９０カ所に工場 |
| 塩野義 | 240,500円 | +5.7% | +3.9% | 2.55% | 11.97倍 | 1.58倍 |
|
抗ＨＩＶ薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
| エーザイ | 405,000円 | +1.7% | -2.9% | 3.95% | 26.57倍 | 1.39倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
市場注目の銘柄
チャート関連のコラム
